Mali vs United States of America: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Mali
83.0%
in 2024
United States of America
84.0%
in 2024
Mali rank
94th
United States of America rank
92nd
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Mali
- United States of America
How they compare
United States of America currently reports 84.0% against 83.0% in Mali, a difference of 1.0%.
Across all 14 years both countries report, United States of America has been ahead every year.
Mali ranks 94th and United States of America ranks 92nd of 146 countries.
United States of America has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mali | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.2% | 92.6% | 26.3% | United States of America |
| 2020s | 75.2% | 83.2% | 8.0% | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Mali or United States of America?
- United States of America, at 84.0% against 83.0% in Mali as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Mali and United States of America?
- 1.0%, with United States of America ahead.
- How many years of comparable data are there for Mali and United States of America?
- 14 years are reported by both, from 2011 to 2024.
- How do Mali and United States of America rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Mali ranks 94th and United States of America ranks 92nd of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.